By Justin Petrone

Roche reported last week that its microarray revenues grew by more than a quarter in the first half of this year.

Sales of Roche NimbleGen products climbed 26 percent for the first sixth months of 2010, buoyed by strong reagent sales, which were up 63 percent compared to the same period of 2009.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.